Skip to main content
OpenTrials

Clinical trial condition

Muscular Disorders, Atrophic

Explore clinical trials studying Muscular Disorders, Atrophic. Study availability and eligibility vary by location and protocol.

622 public trials 123 recruiting studies
Refine in advanced search Browse all conditions

Muscular Disorders, Atrophic trial results

Completed

Evaluation of a Textile Scapula Orthosis

NCT04154098

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Muscle Weakness, +15 more
Locations
  • Kliniken Schmieder Konstanz Konstanz, Basen-Wuerttemberg, Germany
  • ETH Zurich Zurich, Switzerland
View Trial Details
Completed

Study of Ataluren for Previously Treated Participants With Nonsense Mutation Duchenne/Becker Muscular Dystrophy (nmDBMD) in Europe, Israel, Australia, and Canada

NCT01557400

Conditions
Becker Muscular Dystrophy, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Duchenne Muscular Dystrophy, +10 more
Locations
  • Royal Children's Hospital Parkville, Melbourne, Australia
  • Institute For Neuromuscular Research, The Children's Hospital at Westmead Westmead, Australia
  • University Hospital KU Leuven Leuven, Belgium
  • Alberta Children's Hospital Calgary, Alberta, Canada
View all 21 locations
View Trial Details
Completed

Phase I/II Study of SRP-4053 in DMD Patients

NCT02310906

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Duchenne Muscular Dystrophy, Genetic Diseases, Inborn, +8 more
Locations
  • Boston Children's Hospital Boston, Massachusetts, United States
  • Institute de Myologie Paris, France
  • Policlinico Universitario A Gemelli Rome, Italy
  • Great Ormond Street Hospital for Children NHS Foundation Trust London, United Kingdom
View Trial Details
Completed

An Efficacy and Safety Trial of Intravenous Zoledronic Acid Twice Yearly in Osteoporotic Children Treated With Glucocorticoids

NCT00799266

Conditions
Bone Diseases, Bone Diseases, Metabolic, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +12 more
Locations
  • Novartis Investigative Site Westmead, New South Wales, Australia
  • Novartis Investigative Site Vancouver, British Columbia, Canada
  • Novartis Investigative Site Winnipeg, Manitoba, Canada
  • Novartis Investigative Site Ottawa, Ontario, Canada
View Trial Details
Completed

Study of Ataluren in ≥2 to <5 Year-Old Male Participants With Duchenne Muscular Dystrophy

NCT02819557

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Duchenne Muscular Dystrophy, Genetic Diseases, Inborn, +8 more
Locations
  • Child Neuro NWF Gulf Breeze, Florida, United States
  • Rush University Medical Center Chicago, Illinois, United States
  • Children's Hospital Boston Boston, Massachusetts, United States
  • Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States
View Trial Details

Related conditions